Strictly Laboratory Research Use Only: Not approved for human or clinical consumption. HPLC Purity Tested (≥99%).

Purity:

PT-141 10MG — BREMELANOTIDE

Vial Size / Concentration: 

$110.00

/ vial

Melanocortin, Sexual-Arousal & Neuroendocrine Research Peptide

PT-141, also known as bremelanotide, is a synthetic melanocortin peptide studied for its activity at melanocortin receptors, particularly MC3R and MC4R. Unlike compounds that act primarily through peripheral blood-flow mechanisms, PT-141 research focuses on central nervous-system pathways involved in sexual motivation and arousal.

Research has investigated PT-141 signaling in both male and female models, including mechanisms associated with sexual desire, arousal, erectile response, and neuroendocrine regulation. Its effects are linked to melanocortin pathways within brain regions involved in sexual behavior rather than simply increasing genital blood flow.

PT-141 is particularly notable because bremelanotide has been clinically developed and FDA-approved as a prescription drug for a specific sexual-desire disorder in certain premenopausal women; however, a research-labeled PT-141 product should not be represented as that approved prescription product.

Research Focus: Sexual-Arousal Pathways • Libido & Desire Research • MC3R/MC4R Signaling • Melanocortin System • CNS Signaling • Erectile-Response Research • Female Sexual-Function Research • Neuroendocrine Biology

Contents: PT-141 (Bremelanotide) — 10 mg

RESEARCH USE ONLY NOT FOR HUMAN OR ANIMAL USE

CAS Number:

Molecular Formula:

Molecular Weight:

Appearance:

ISO 9001:2015 Verified Laboratory Compound

Submit Research Specification

All synthesis requests are handled under rigorous laboratory non-disclosure agreements.